Immuneering (IMRX) Times Interest Earned (2020 - 2026)
Immuneering's (IMRX) quarterly Times Interest Earned came in at -$0.85 in Q1 2026, up 98.99% year-on-year from -$0.43 in Q1 2025, and up 98.83% quarter-over-quarter from -$72.75 in Q4 2025.
Immuneering (IMRX) Times Interest Earned (2020 - 2026) Analysis & Trends
Immuneering's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.85 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 98.99% year-over-year to -$0.85 in Q1 2026; TTM through Mar 2026 was -$3.28, a 96.16% increase from a year earlier, with the FY2025 full-year figure at -$0.81, up 25.49% from the prior year.
- Times Interest Earned improved to -$0.85 in Q1 2026 per IMRX's latest filing, from -$72.75 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.51 in Q3 2022 and bottomed at -$107.73 in Q4 2022.
- The 5-year median for Times Interest Earned is -$2.48 (2024), against an average of -$36.05.
- Across the five-year window, Times Interest Earned plunged 2672.66% in 2023 and jumped 98.99% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$107.73 in 2022, then increased by 21.43% to -$84.64 in 2023, then retreated by 19.46% to -$101.11 in 2024, then advanced by 28.05% to -$72.75 in 2025, then surged by 98.83% to -$0.85 in 2026.
- Per Business Quant, the three latest IMRX Times Interest Earned figures stand at -$0.85 (Q1 2026), -$72.75 (Q4 2025), and -$0.52 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - | -0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.85 |
| Dec 31, 2025 | -72.75 |
| Sep 30, 2025 | -0.52 |
| Jun 30, 2025 | -2.63 |
| Mar 31, 2025 | -84.36 |
| Dec 31, 2024 | -101.11 |
| Sep 30, 2024 | -2.48 |
| Jun 30, 2024 | -2.36 |
| Mar 31, 2024 | -79.57 |
| Dec 31, 2023 | -84.64 |
| Sep 30, 2023 | -1.08 |
| Jun 30, 2023 | -0.61 |
| Mar 31, 2023 | -67.76 |
| Dec 31, 2022 | -107.73 |
| Sep 30, 2022 | -0.51 |
| Jun 30, 2022 | -1.48 |
| Mar 31, 2022 | -2.44 |
| Dec 31, 2021 | -391.86 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2021 | -0.69 |